» Articles » PMID: 36146746

Recombinant Mammalian Prions: The "Correctly" Misfolded Prion Protein Conformers

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2022 Sep 23
PMID 36146746
Authors
Affiliations
Soon will be listed here.
Abstract

Generating a prion with exogenously produced recombinant prion protein is widely accepted as the ultimate proof of the prion hypothesis. Over the years, a plethora of misfolded recPrP conformers have been generated, but despite their seeding capability, many of them have failed to elicit a fatal neurodegenerative disorder in wild-type animals like a naturally occurring prion. The application of the protein misfolding cyclic amplification technique and the inclusion of non-protein cofactors in the reaction mixture have led to the generation of authentic recombinant prions that fully recapitulate the characteristics of native prions. Together, these studies reveal that recPrP can stably exist in a variety of misfolded conformations and when inoculated into wild-type animals, misfolded recPrP conformers cause a wide range of outcomes, from being completely innocuous to lethal. Since all these recPrP conformers possess seeding capabilities, these results clearly suggest that seeding activity alone is not equivalent to prion activity. Instead, authentic prions are those PrP conformers that are not only heritable (the ability to seed the conversion of normal PrP) but also pathogenic (the ability to cause fatal neurodegeneration). The knowledge gained from the studies of the recombinant prion is important for us to understand the pathogenesis of prion disease and the roles of misfolded proteins in other neurodegenerative disorders.

Citing Articles

Proliferative arrest induces neuronal differentiation and innate immune responses in normal and Creutzfeldt-Jakob Disease agent (CJ) infected rat septal neurons.

Pagano N, Perez G, Garcia-Milian R, Manuelidis L bioRxiv. 2024; .

PMID: 39131355 PMC: 11312452. DOI: 10.1101/2024.07.26.605349.


Advanced Situation with Recombinant Toxins: Diversity, Production and Application Purposes.

Efremenko E, Aslanli A, Lyagin I Int J Mol Sci. 2023; 24(5).

PMID: 36902061 PMC: 10003545. DOI: 10.3390/ijms24054630.

References
1.
Colby D, Zhang Q, Wang S, Groth D, Legname G, Riesner D . Prion detection by an amyloid seeding assay. Proc Natl Acad Sci U S A. 2007; 104(52):20914-9. PMC: 2409241. DOI: 10.1073/pnas.0710152105. View

2.
Hoyt F, Standke H, Artikis E, Schwartz C, Hansen B, Li K . Cryo-EM structure of anchorless RML prion reveals variations in shared motifs between distinct strains. Nat Commun. 2022; 13(1):4005. PMC: 9279418. DOI: 10.1038/s41467-022-30458-6. View

3.
Hall S, Orru C, Serrano G, Galasko D, Hughson A, Groveman B . Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body disease. Acta Neuropathol Commun. 2022; 10(1):90. PMC: 9219141. DOI: 10.1186/s40478-022-01388-7. View

4.
Imamura M, Kato N, Okada H, Yoshioka M, Iwamaru Y, Shimizu Y . Insect cell-derived cofactors become fully functional after proteinase K and heat treatment for high-fidelity amplification of glycosylphosphatidylinositol-anchored recombinant scrapie and BSE prion proteins. PLoS One. 2013; 8(12):e82538. PMC: 3867355. DOI: 10.1371/journal.pone.0082538. View

5.
Baron G, Caughey B . Effect of glycosylphosphatidylinositol anchor-dependent and -independent prion protein association with model raft membranes on conversion to the protease-resistant isoform. J Biol Chem. 2003; 278(17):14883-92. DOI: 10.1074/jbc.M210840200. View